أعرض في EDS

POSA236 Real-World Treatment (Tx) Characteristics for Advanced Non-Small Cell Lung Cancer (aNSCLC) Without Actionable Mutations After Introduction of Immune Checkpoint Inhibitors (ICIs) in EU4 and UK

التفاصيل البيبلوغرافية
العنوان: POSA236 Real-World Treatment (Tx) Characteristics for Advanced Non-Small Cell Lung Cancer (aNSCLC) Without Actionable Mutations After Introduction of Immune Checkpoint Inhibitors (ICIs) in EU4 and UK
المؤلفون: J Multani, V Casey, S Mpima, M Yasuda, CC Chen, F Manuguid, L Kalilani, TJ Giove, J Chao, A Aziez, A Stojadinovic, C Hogea
المصدر: Value in Health. 25:S154-S155
بيانات النشر: Elsevier BV, 2022.
سنة النشر: 2022
مصطلحات موضوعية: Health Policy, Public Health, Environmental and Occupational Health
تدمد: 1098-3015
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::18d9037289800497b02e17e65ec8385d
https://doi.org/10.1016/j.jval.2021.11.751
حقوق: CLOSED
رقم الأكسشن: edsair.doi...........18d9037289800497b02e17e65ec8385d
قاعدة البيانات: OpenAIRE
الوصف
تدمد:10983015